Skip to main content
. 2019 Mar 15;14(3):e0213774. doi: 10.1371/journal.pone.0213774

Fig 1. Trials included in the integrated safety analysis.

Fig 1

*Trial NCT01785875 also contains data from patients enrolled from a single-arm parent trial (i.e., trial NCT01932970). Trial NCT02102204 also contains data from patients enrolled from a phase 2 parent trial (i.e., trial NCT01576146). Indicates unique patients in the OLE pool. Ca = calcium; QD = every day; IV = intravenous; sHPT = secondary hyperparathyroidism; TIW = three times weekly.